Who are Sanjin tablets simulants's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Shenlingcao Oral Liquid, Compound Kushen Injection（CKI）, Abelmoschus manihot (AM), Group S+P, Placebo of Gastrodia and Uncaria granule, Wen Xin granule.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sanjin-tablets-simulants.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Sanjin tablets simulants — Competitive Intelligence Brief

Sanjin tablets simulants (Sanjin tablets simulants) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese medicine. Area: Cardiovascular / Hematology.

marketed Traditional Chinese medicine Cardiovascular / Hematology Small molecule Live · refreshed every 30 min

Target snapshot

Sanjin tablets simulants (Sanjin tablets simulants) — China Academy of Chinese Medical Sciences. Sanjin tablets is a traditional Chinese medicine formulation that promotes blood circulation and removes blood stasis to treat inflammatory and thrombotic conditions.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Sanjin tablets simulants TARGET	Sanjin tablets simulants	China Academy of Chinese Medical Sciences	marketed	Traditional Chinese medicine
Shenlingcao Oral Liquid	Shenlingcao Oral Liquid	West China Hospital	marketed	Traditional Chinese Medicine	Immune system
Compound Kushen Injection（CKI）	Compound Kushen Injection（CKI）	Shanxi Zhendong Pharmacy Co., Ltd	marketed	Herbal extract / Traditional Chinese medicine
Abelmoschus manihot (AM)	Abelmoschus manihot (AM)	Chinese PLA General Hospital	marketed	Herbal extract / Traditional Chinese Medicine
Group S+P	Group S+P	Huazhong University of Science and Technology	marketed	Traditional Chinese medicine herbal combination
Placebo of Gastrodia and Uncaria granule	Placebo of Gastrodia and Uncaria granule	Shanghai Institute of Hypertension	marketed	Herbal medicine / Traditional Chinese medicine
Wen Xin granule	Wen Xin granule	Guang'anmen Hospital of China Academy of Chinese Medical Sciences	marketed	Traditional Chinese medicine herbal granule

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese medicine class)

Shanghai University of Traditional Chinese Medicine · 2 drugs in this class
Jiangsu Famous Medical Technology Co., Ltd. · 2 drugs in this class
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · 1 drug in this class
Sichuan Jishengtang Pharmaceutical Co., Ltd. · 1 drug in this class
Tasly Pharmaceutical Group Co., Ltd · 1 drug in this class
China Academy of Chinese Medical Sciences · 1 drug in this class
The First Affiliated Hospital of Guangzhou Medical University · 1 drug in this class
Dongzhimen Hospital, Beijing · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sanjin tablets simulants — Competitive Intelligence Brief. https://druglandscape.com/ci/sanjin-tablets-simulants. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab